S10 Ep22: CRC Experts Highlight AE Management and Prevention Strategies for TAS-102/Bevacizumab, Regorafenib, and Fruquintinib

OncLive® On Air - Un podcast de OncLive® On Air

Essayez Nextory gratuitement pendant un mois.

Un univers rempli de livres audio, cliquez ici pour essayer

Strickler, Leung, Dasari, and O'Neill discuss adverse effect monitoring and management with standard agents for patients with colorectal cancer.